Results 81 to 90 of about 876 (115)

Extending the Antiviral Value of Favipiravir [PDF]

The Journal of Infectious Diseases, 2018
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Favipiravir

Reactions Weekly, 2023
  +12 more sources

Favipiravir in Therapy of Viral Infections [PDF]

Journal of Clinical Medicine, 2021
Favipiravir (FPV) is a novel antiviral drug acting as a competitive inhibitor of RNA-dependent RNA polymerase (RdRp), preventing viral transcription and replication. FPV was approved in Japan in 2014 for therapy of influenza unresponsive to standard antiviral therapies.
Andrzej Pawlik, Patrycja Klos, Ryta Łagocka   +2 more
exaly   +3 more sources

Favipiravir in the Battle with Respiratory Viruses

Mini-Reviews in Medicinal Chemistry, 2022
Abstract: Among antiviral drugs, the vast majority targets only one or two related viruses. The conventional model, one virus - one drug, significantly limits therapeutic options. Therefore, in the strategy of controlling viral infections, there is a necessity to develop compounds with pleiotropic effects.
Anna Majewska, Julia M. Smyk
openaire   +2 more sources

Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

International Journal of Infectious Diseases, 2021
Saiprasad Patil, Amol Pendse, Jatin Kadam   +2 more
exaly  

Dexamethasone/favipiravir

Reactions Weekly, 2022
openaire   +2 more sources

Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial

European Journal of Pharmaceutical Sciences, 2021
Yao Hp, Yan Lou, Xiaoyang Lu
exaly  

Dexamethasone/favipiravir

Reactions Weekly, 2023
openaire   +2 more sources

Spectrofluorimetric quantitative analysis of favipiravir, remdesivir and hydroxychloroquine in spiked human plasma

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2022
Sherif Ramzy, Ahmed Hussien, Mohamed Hasan   +2 more
exaly  

The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model

EBioMedicine, 2021
Lana Langendries, Judith Breuer, Xin Zhang   +2 more
exaly